Quince Therapeutics, Inc. (QNCX): SCHEDULE 13G filed Aug 14, 2026

Form type
SCHEDULE 13G
Filing date
Aug 14, 2026
Accession number
0001172661-26-003433
Filer
Quince Therapeutics, Inc. (CIK 1662774)